Alexia Iasonos

28PUBLICATIONS
202CO-AUTHORS
Molecular targetsPredictive and prognostic markersForensic epidemiologyChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 14, 2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Jan 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.

Judy J Wang, Juliet Milani, Sarah Kane

|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Early-Phase Trials Using Innovative Trial Designs and Biomarkers.

Olanrewaju O Okusanya, Gabriela I Patilea-Vrana, Anthony Sireci

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|May 19, 2025
Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-Inferiority.

Hakim-Moulay Dehbi, Sean Devlins, Alexia Iasonos

Pageof 5

Frequent Collaborators

11 joint publications

Qin Zhou

11 joint publications

Britta Weigelt

8 joint publications

Carol Aghajanian

7 joint publications

Pier Selenica